Publication Name	World Journal of Gastroenterology
Manuscript ID	55458
Country	United States

Received	2020-03-18 16:52
Peer-Review Started	2020-03-18 16:56
To Make the First Decision
Return for Revision	2020-05-15 23:47
Revised	2020-06-18 16:16
Second Decision	2020-06-22 10:06
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2020-06-23 01:21
Articles in Press	2020-06-23 01:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2020-06-30 12:46
Publish the Manuscript Online	2020-07-07 14:50

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease
Manuscript Source	Invited Manuscript
All Author List	Matteo Tardelli
Funding Agency and Grant Number
Corresponding Author	Matteo Tardelli, MSc, PhD, Lecturer, Postdoctoral Fellow, Division of Gastroenterology and Hepatology, Joan and Sanford I Weill Cornell Department of Medicine, Weill Cornell Medical College, 413 E. 69th Street, New York, NY 10013, United States. mat4005@med.cornell.edu
Key Words	Lipid metabolism; Monoacylglycerol lipase; Non-alcoholic steatohepatitis; Non-alcoholic fatty liver disease; Cannabinoid; Nuclear receptors
Core Tip	Monoacylglycerol lipase inhibition/modulation is yet unappreciated however attractive therapeutic concept to limit liver disease as fatty acids may drive hepatocyte injury, fibrogenesis and change immune cells phenotype.
Publish Date	2020-07-07 14:50
Citation	Tardelli M. Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease. World J Gastroenterol 2020; 26(25): 3577-3585
URL	https://www.wjgnet.com/1007-9327/full/v26/i25/3577.htm
DOI	https://dx.doi.org/10.3748/wjg.v26.i25.3577

Full Article (PDF)	WJG-26-3577.pdf
Full Article (Word)	WJG-26-3577.docx
Manuscript File	55458-Review.docx
Answering Reviewers	55458-Answering reviewers.pdf
Audio Core Tip	55458-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	55458-Conflict-of-interest statement.pdf
Copyright License Agreement	55458-Copyright license agreement.pdf
Peer-review Report	55458-Peer-review(s).pdf
Scientific Misconduct Check	55458-Bing-Yan JP-1.png
Scientific Misconduct Check	55458-Scientific misconduct check.pdf
Scientific Editor Work List	55458-Scientific editor work list.pdf